At KPMG, I led due diligence investigations into individuals, companies, and other entities, identifying potential compliance and reputational risks.
I used public records, proprietary databases, and OSINT tools to research risk indicators, review ownership structures, and support the identification of ultimate beneficial owners. I also conducted PEP, sanctions, and adverse-media screening.
Across 10+ M&A and joint-venture engagements, I assessed financial, operational, and market risks. I prepared 30+ reports with investigation findings, risk ratings, and recommendations for senior stakeholders.
As a Research Analyst intern at Mendine Pharmaceuticals Private Limited, I analyzed market and clinical datasets using Microsoft Excel and SQL to inform product development decisions. I also prepared regulatory submission documentation and designed tools for primary research.
